ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Boehringer Ingelheim To Build Tech Center

by Ann M. Thayer
June 11, 2012 | APPEARED IN VOLUME 90, ISSUE 24

[+]Enlarge
Credit: Boehringer Ingelheim
An artist’s rendering of the new tech center slated for Biberach.
09024-buscon-buildingcxd.jpg
Credit: Boehringer Ingelheim
An artist’s rendering of the new tech center slated for Biberach.

Boehringer Ingelheim will spend more than $62 million to build a facility for producing new active pharmaceutical ingredients at the company’s Biberach, Germany, site. The new facility will make clinical-scale quantities of compounds arising from the firm’s own drug development pipeline. The pilot plant facility will have 15 reactors with volumes from 100 to 300 L and four manufacturing bays, including four synthesis labs for scale-up work. Boehringer expects to complete construction of the plant and associated tech center in early 2014.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment